|
Home | Technology News Search Engine:
|
|
|
|
Home: Technology News:
|
|
|
(IT-NEWSWIRE.COM, June 22, 2017 ) The Global Preclinical in-vivo imaging market has been estimated at USD 745 Million in 2016 and is projected to reach USD 1004.05 Million by 2021, at a CAGR of 6.15% during the forecast period from 2016 to 2021. Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities are very crucial for researchers in observing changes, either at the organ, tissue, cell, or molecular level, responding to physiological or environmental changes. Imaging modalities that are non-invasive and in-vivo is important to study animal models longitudinally. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are usually used for anatomical imaging, while optical imaging (fluorescence and bioluminescence), positron emission tomography (PET), and single photon emission computed tomography (SPECT) are usually used for molecular visualizations. Pre-clinical in-vivo imaging industry has experienced myriad technological advancements, changes in market due to industry consolidation, and change in government funding and support for research studies across the global over the past decade.
Browse market data tables and in-depth TOC of the Global Preclinical In-vivo Imaging Market to 2021 @ http://www.marketdataforecast.com/market-reports/global-preclinical-in-vivo-imaging-market-582/
Globally, factors such as technological advancements in molecular imaging modalities, growing acceptance of preclinical imaging as a legitimate drug development tool, are fueling the demand of preclinical imaging systems and reagents. Declining NIH budgets for medical science research studies and high implementation cost of sophisticated preclinical imaging systems are restricting the growth of the global preclinical imaging market.
Global market for Preclinical In-vivo Imaging is segmented based on Modality and Reagents. Based on modality, the global preclinical imaging market is divided into seven major segments, namely, optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems. The preclinical optical imaging systems market includes bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems, optical + X-ray/optical + CT imaging systems. The preclinical nuclear imaging systems market comprises micro-PET systems (standalone PET, PET/CT, and PET/MRI), micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI), and tri-modality (PET/SPECT/CT) imaging systems. Bases on the reagents, the global preclinical imaging market is divided into five segments, namely, optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. The optical imaging reagents market is further sub-segmented as bioluminescent and fluorescent imaging reagents. Likewise, the nuclear imaging reagents market is divided as preclinical PET tracers and SPECT probes.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/global-preclinical-in-vivo-imaging-market-582/request-sample
Geographically, Global market for Preclinical In-vivo Imaging is segmented into North America, Asia Pacific, Latin America, Europe, and Africa & Middle-East. North America holds the largest share of the global preclinical imaging market, followed by Europe. Factors including rising R&D activities by big pharma and biotech companies in developing nations and increased government funding for development of pharmaceutical industry are stimulating the growth of the preclinical imaging market in the Asia-Pacific region.
Aspect Imaging, Biospace Lab S.A., Bruker Corporation, LI-COR Biosciences, Mediso Ltd., MILabs B.V., MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging, and FUJIFILM VisualSonics, Inc. are the key players operating in the global preclinical imaging systems market.
Avail discount @ http://www.marketdataforecast.com/market-reports/global-preclinical-in-vivo-imaging-market-582/request-discount
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
|
Technology News Headlines
|
|
|
|
|
Technology Business Video Feed
|
|
More Technology Video Feeds
|
|
|
